Hands-on Demonstrations Delight High School STEM StudentsHands-on Demonstrations Delight High School STEM Students
PhD Student-led Demonstrations Demystify BiotechnologyPhD Student-led Demonstrations Demystify Biotechnology
High School STEM Students Explore Northwestern LabsHigh School STEM Students Explore Northwestern Labs
Prospective Master's Students Visit MBP FacilitiesProspective Master's Students Visit MBP Facilities
Industry Panelists Share Their Career Insights Industry Panelists Share Their Career Insights
AbbVie's Francisco Rausa Delivers Keynote SpeechAbbVie's Francisco Rausa Delivers Keynote Speech
Guests Enjoy Biotechnology Day ReceptionGuests Enjoy Biotechnology Day Reception

Seminars & Events
Biotechnology Day

Each year, Northwestern University's Master of Biotechnology Program (MBP) hosts Biotechnology Day, a one-day life sciences festival designed to inspire and inform curious minds. We aim to reach a broad community of students, scientists, and science enthusiasts through our programming on:

  • K-12 STEM Education
  • Biotechnology Workforce Development
  • Community Based Biotechnology (a.k.a. Biohacking, DIYbio, etc.)

This year's event includes community outreach activities, tours of facilities, career panels (technical and non-technical focuses), a keynote speech by Dr. Jeffrey Baker (Deputy Director of the FDA), and an open networking session. 

MBP's next Biotechnology Day is on March 2, 2018. Our schedule is included below. Attendance is free but registration is required. Registration closes on Friday, February 26 at 12:00pm CST. 

Register for Biotechnology Day


Speaker: Jeffrey C. Baker, Ph.D. (Deputy Director, Office of Biotechnology Products, Center for Drug Evaluation and Research at the United States FDA)

About the Speaker: Dr. Baker received a bachelor’s degree in biochemistry and molecular biology at Northwestern University, his doctorate in biochemistry from the University of North Texas, and completed post-doctoral studies at the University of California, Berkeley. Dr. Baker joined the biosynthetic process development group at Eli Lilly & Co in 1988. While at Lilly, Dr. Baker led the development of several biologics from bench top purification to global launch, supported post-launch manufacturing process development activities, and established and led Lilly’s Global Validation Practices Team. After completing his certification as a Lean Six Sigma Black Belt, Dr. Baker led several corporate initiatives related to assessment and enhancement of control, capability, and functional governance processes in pharmaceutical manufacturing. Dr. Baker left Lilly to be Sr. Director of Manufacturing Science and Technology at MedImmune, a subsidiary of AstraZeneca. In 2011, Dr. Baker was appointed Deputy Director of the Office of Biotechnology Products in the Center for Drug Evaluation and Research at the FDA. Dr. Baker helped establish the Quality Management System used today in OBP and has been recognized with several CDER citations for leadership and program development. He was a member of the team which conceptualized and stood up the Office of Pharmaceutical Quality at FDA.

Title: "The Development, Manufacture, and Regulation of Biopharmaceuticals in the United States"

Abstract: We are in the midst of an explosion of creativity and innovation in the development of biotechnology based pharmaceuticals. New technologies and manufacturing strategies, therapeutic proteins addressing unmet medical needs, curative biotherapeutics, biosimilars, and products rushed to market with breakthrough status are all on the rise. The combination of technological innovation, a rapidly evolving regulatory landscape, and global market requirements can paint a picture of daunting or energizing complexity. This talk will provide an overview of the regulation of biopharmaceuticals in the United States and explore the current regulatory paradigm of patient centered, risk based oversight employing a totality of evidence framework to assure stable supplies of high quality medicines, a totality of evidence based upon data driven studies, first principle understanding, and sound engineering practices in manufacturing.

For more information about panelists, please visit our registration page.


November 10, 2016

November's event at Norris University Center was a huge success, thanks largely to our co-sponsors, the Office of STEM Education Partnerships (OSEP) and the Biotechnology Training Program (BTP) at Northwestern University. With their help, we were able to engage, educate, and connect nearly 200 members of the scientific community!

Students from Curie Metropolitan High School, Beacon Academy, and Evanston Township High School participated in hands-on activities and small-scale scientific experiments before exploring career paths in the biotechnology field through conversations with industry professionals and Northwestern PhD students. Their visit concluded with an extensive tour of the Northwestern University campus and various laboratory facilities.

The afternoon portion of Biotechnology Day was open to curious members of the community as well as students from the Master of Biotechnology Program. Technical and non-technical career panels comprised of 14 industry professionals representing 13 different companies delved into the details of the many diverse career possibilities offered by the biotechnology field. Francisco Rausa, Senior Principal Research Scientist at AbbVie, delivered a keynote speech which highlighted his work at AbbVie as well as exciting trends emerging in the industry. The evening concluded with an open networking session and reception in the gorgeous Ryan Center for the Musical Arts, overlooking downtown Chicago and the lake.

We would like to thank everyone for a wonderful Biotechnology Day. We hope to see you again next year—until then, stay curious!

Click here to view the complete Biotechnology Day schedule, or view it below!

February 26, 2016

In February of 2016, MBP hosted its day-long event in the atrium of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. Guests enjoyed industry panels, biotech demonstrations, and keynote speaker Nicole Fisher (HHR Strategies).